Anti-RNF128 monoclonal antibody

Pre-made anti-RNF128 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RNF128/RNF128 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1504-Ab-1/ GM-Tg-hg-IP1504-Ab-2Anti-Human RNF128 monoclonal antibodyHuman
GM-Tg-rg-IP1504-Ab-1/ GM-Tg-rg-IP1504-Ab-2Anti-Rat RNF128 monoclonal antibodyRat
GM-Tg-mg-IP1504-Ab-1/ GM-Tg-mg-IP1504-Ab-2Anti-Mouse RNF128 monoclonal antibodyMouse
GM-Tg-cynog-IP1504-Ab-1/ GM-Tg-cynog-IP1504-Ab-2Anti-Cynomolgus/ Rhesus macaque RNF128 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1504-Ab-1/ GM-Tg-felg-IP1504-Ab-2Anti-Feline RNF128 monoclonal antibodyFeline
GM-Tg-cang-IP1504-Ab-1/ GM-Tg-cang-IP1504-Ab-2Anti-Canine RNF128 monoclonal antibodyCanine
GM-Tg-bovg-IP1504-Ab-1/ GM-Tg-bovg-IP1504-Ab-2Anti-Bovine RNF128 monoclonal antibodyBovine
GM-Tg-equg-IP1504-Ab-1/ GM-Tg-equg-IP1504-Ab-2Anti-Equine RNF128 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1504-Ab-1/ GM-Tg-hg-IP1504-Ab-2; GM-Tg-rg-IP1504-Ab-1/ GM-Tg-rg-IP1504-Ab-2;
GM-Tg-mg-IP1504-Ab-1/ GM-Tg-mg-IP1504-Ab-2; GM-Tg-cynog-IP1504-Ab-1/ GM-Tg-cynog-IP1504-Ab-2;
GM-Tg-felg-IP1504-Ab-1/ GM-Tg-felg-IP1504-Ab-2; GM-Tg-cang-IP1504-Ab-1/ GM-Tg-cang-IP1504-Ab-2;
GM-Tg-bovg-IP1504-Ab-1/ GM-Tg-bovg-IP1504-Ab-2; GM-Tg-equg-IP1504-Ab-1/ GM-Tg-equg-IP1504-Ab-2
Products NameAnti-RNF128 monoclonal antibody
Formatmab
Target NameRNF128
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RNF128 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1504-Ag-1Recombinant multi-species RN128/ RNF128/ GRAIL protein
    ORF Viral VectorpGMLP004137human RNF128 Lentivirus plasmid
    ORF Viral VectorvGMLP004137human RNF128 Lentivirus particle
    ORF Viral VectorpGMLPm004141mouse Rnf128 Lentivirus plasmid
    ORF Viral VectorvGMLPm004141mouse Rnf128 Lentivirus particle


    Target information

    Target IDGM-IP1504
    Target NameRNF128
    Gene ID79589,66889,315911,700890,492051,101080265,535869,100054821
    Gene Symbol and Synonyms1300002C13Rik,GRAIL,Greul1,RGD1566282,RNF128
    Uniprot AccessionQ8TEB7,Q29RU0
    Uniprot Entry NameRN128_HUMAN,RN128_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000133135
    Target ClassificationN/A

    The target: RNF128, gene name: RNF128, also named as GRAIL. The protein encoded by this gene is a type I transmembrane protein that localizes to the endocytic pathway. This protein contains a RING zinc-finger motif and has been shown to possess E3 ubiquitin ligase activity. Expression of this gene in retrovirally transduced T cell hybridoma significantly inhibits activation-induced IL2 and IL4 cytokine production. Induced expression of this gene was observed in anergic CD4(+) T cells, which suggested a role in the induction of anergic phenotype. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.